Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
ID: 354193Type: Posted
Overview

Buyer

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Original Source

https://grants.gov/search-results-detail/354193

Additional Information

http://grants.nih.gov/grants/guide/pa-files/PAR-24-207.html
Timeline
    Description

    The National Institutes of Health (NIH) is offering a federal grant opportunity titled "Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)" aimed at reducing health disparities related to liver diseases and liver cancer in the United States. This initiative encourages multi-level and multi-domain intervention research that targets racial and ethnic minority populations, individuals with low socioeconomic status, and sexual and gender minorities, with a focus on improving prevention, screening, treatment, and management of liver conditions. The program emphasizes the importance of addressing social determinants of health and utilizing interdisciplinary approaches to enhance health equity and quality of care among underserved communities. Interested applicants must submit their proposals by January 7, 2028, and can find additional information and application guidelines at NIH Grants. For inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov.

    Point(s) of Contact
    grantsinfo@nih.gov
    Files
    Title
    Posted
    PAR-24-207-Full-Announcement.html
    PAR-24-207.html
    The Department of Health and Human Services (HHS), through its National Institutes of Health (NIH), is offering funding opportunities aimed at reducing disparities in liver diseases and liver cancer in the U.S. The initiative supports multi-level intervention research targeting racial and ethnic minority populations, individuals with low socioeconomic status, and sexual and gender minorities. Applications are encouraged to improve prevention, screening, treatment, and management of liver conditions and to engage communities meaningfully. Key considerations include: projects must address social determinants of health (SDOH) affecting health outcomes, utilize interdisciplinary approaches, and include measures for biological, behavioral, and socio-cultural domains. The application deadline is set for February 2024, with awards contingent upon meritorious applications. Applicants must follow stringent submission guidelines and are encouraged to propose culturally sensitive interventions, assess multi-level impacts, and consider diverse populations. The overall goal is to advance health equity and improve quality of care among underserved communities affected by liver disease and liver cancer.
    Similar Opportunities
    Interventions to Address Disparities in Liver Diseases and Liver Cancer (R01 - Clinical Trials Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Interventions to Address Disparities in Liver Diseases and Liver Cancer," aimed at supporting research interventions that target health disparities in liver diseases and liver cancer among marginalized populations in the United States. This initiative encourages researchers to propose multi-level and multi-domain approaches that address social determinants of health, with a focus on improving screening, treatment, and health outcomes for affected groups, including racial and ethnic minorities and individuals with lower socioeconomic status. The grant has no specific budget limit and allows for a maximum project period of five years, with applications accepted starting September 5, 2024. Interested applicants can find more information and contact NIH Grants Information at grantsinfo@nih.gov for inquiries.
    Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for epidemiologic research focused on emerging risk factors associated with liver cancer in the United States, specifically through the R01 grant mechanism. This initiative aims to investigate novel hypotheses regarding biological, environmental, and social factors, as well as their interactions with established risk factors like viral hepatitis, to better understand their role in the development of hepatocellular carcinoma and other liver cancer types. The program encourages applications that explore non-viral contributors, such as obesity and diabetes, and seeks to produce insights that will inform evidence-based strategies for liver cancer prevention and control. Interested applicants, including higher education institutions, nonprofit organizations, and foreign entities, must submit their proposals by February 5, 2025, and can find additional information at NIH Grants. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity for epidemiologic research on emerging risk factors associated with liver cancer, specifically hepatocellular carcinoma and other subtypes. This initiative aims to investigate both novel and established biological, environmental, and social risk factors that contribute to liver cancer development in the United States, with a focus on understanding the interplay of these factors. The funding is available through the Research Project Grant (R01) mechanism for projects lasting up to five years, and applications are encouraged from a diverse range of eligible applicants, including educational institutions and community organizations. Interested parties should note that the application deadline is May 7, 2025, and can find more information at the provided NIH link or contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov for further inquiries.
    Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity for epidemiologic research on emerging risk factors associated with liver cancer in the United States, specifically through the R21 Clinical Trial Not Allowed mechanism. This initiative aims to explore innovative hypotheses regarding biological, environmental, and social risk factors, while excluding applications focused solely on viral hepatitis as the etiologic factor. The research is crucial for informing prevention strategies and addressing the rising rates of liver cancer, particularly hepatocellular carcinoma, among various U.S. populations. Interested applicants can apply for a budget of up to $275,000 over two years, with the application process opening on January 16, 2025, and the submission deadline set for May 7, 2025. For further inquiries, applicants may contact NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PA-25-123.html.
    Epidemiologic Research on Emerging Risk Factors and Liver Cancer Susceptibility (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is inviting applications for the R21 Exploratory/Developmental Research Grant focused on epidemiologic research related to liver cancer susceptibility and emerging risk factors. This funding opportunity aims to investigate both established risk factors, such as viral hepatitis, and novel influences, including environmental and social factors, that contribute to liver cancer incidence in the United States. The initiative underscores the increasing recognition of liver cancer's rising incidence and the need for targeted public health strategies, with a funding limit of $275,000 available over two years. Interested applicants must adhere to NIH guidelines and submit their applications by May 7, 2025; for further inquiries, they can contact the NIH OER Webmaster at OERWebmaster03@od.nih.gov.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities" (R01, Clinical Trial Required). This initiative aims to solicit applications for projects that identify and address barriers to cancer screening and preventive services, particularly in underserved populations, through multi-level interventions involving patients, clinicians, healthcare settings, and community partners. The focus is on developing evidence-based strategies to improve cancer outcomes for groups such as Black Americans, Hispanics, and Native Americans, emphasizing health equity and structured research methodologies. Interested applicants can find more details and submit proposals by January 7, 2027, with the first application due date being October 5, 2023. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov, and further information is available at NIH Grants.
    Interventions to expand cancer screening and preventive services to ADVANCE health in populations that experience health disparities (R01, Clinical Trial Required)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity through the R01 Research Project Grant to enhance cancer screening and preventive services for populations experiencing health disparities. This initiative aims to address barriers to cancer care by developing interventions that operate at multiple levels, including patient, clinician, healthcare settings, and community factors, while encouraging collaboration with community partners. The funding reflects NIH's commitment to advancing health equity, particularly for historically underserved groups, and requires applicants to submit a Plan for Enhancing Diverse Perspectives. Interested applicants can find more information and guidelines at the provided link, with applications due by January 7, 2027. For inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
    Community Level Interventions to Improve Minority Health and Reduce Health Disparities (R01 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a funding opportunity titled "Community Level Interventions to Improve Minority Health and Reduce Health Disparities" (R01 - Clinical Trial Optional), aimed at supporting research that develops and tests community-level interventions to enhance minority health and mitigate health disparities. Applicants are encouraged to form collaborative partnerships with community organizations and must focus on innovative, sustainable initiatives that address health disparities through community-level determinants, employing a conceptual model to connect interventions with health outcomes. The grant provides up to $1 million in direct costs per year for a project duration of up to five years, with applications due by January 7, 2027. For further information, interested parties can contact NIH Grants Information at grantsinfo@nih.gov or visit the opportunity's webpage at https://grants.nih.gov/grants/guide/pa-files/PAR-24-231.html.
    Basic Research in Cancer Health Disparities (R01 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a Notice of Funding Opportunity (NOFO) for the Basic Research in Cancer Health Disparities grant, aimed at supporting innovative research into the biological and genetic causes of cancer health disparities among diverse racial and ethnic populations. This grant encourages applications from a wide range of eligible applicants, including higher education institutions, nonprofits, and organizations serving underrepresented groups, with a focus on mechanistic studies, new methodologies, and the use of biospecimens to uncover cancer risk factors and develop prevention strategies. The application process opens on January 5, 2025, with the first submission deadline on February 5, 2025, and interested parties can reach out to NIH Grants Information at grantsinfo@nih.gov for further inquiries. More details can be found at the provided link: https://grants.nih.gov/grants/guide/pa-files/PAR-25-243.html.
    Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) is offering a grant opportunity titled "Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)" aimed at investigating the biological and genetic mechanisms underlying cancer health disparities among diverse racial and ethnic populations. This funding initiative encourages innovative pilot studies that focus on identifying cancer risk factors, developing preventative strategies, and enhancing research methodologies, while fostering a multidisciplinary cohort dedicated to cancer health disparities research. Eligible applicants include a wide range of entities such as educational institutions, nonprofits, and tribal organizations, with a maximum funding amount of $275,000 available for a two-year project period. Interested parties should note that the application deadline is November 16, 2027, and can direct inquiries to NIH Grants Information at grantsinfo@nih.gov or visit the additional information link at https://grants.nih.gov/grants/guide/pa-files/PAR-25-244.html for further details.